Projected Stock Price
Estimated share price by August 21, 2026.
Projected Revenue
No data available.
Projected Earnings Per Share
Estimated quarterly earnings by December 31, 2026.
Price Target
The average one-year price target for Eli Lilly and Company is CLP874,775.95. The forecasts range from a low of CLP655,231.49 to a high of CLP1,200,897.31.
Update Frequency: Monthly
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for Eli Lilly and Company. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
In addition to being able to interpret financial data, stock analysts have connections within the companies they cover that give them access to information retail investors do not have.
Therefore, analyst ratings can help you find opportunities in the market. However, they are guidelines more than recommendations. This is why it’s important to look at analyst ratings over a period of time.
If analysts change their ratings frequently, you should pay close attention to the company’s fundamentals. For example, has there been a significant change to the company’s earnings growth and/or debt?
You should also pay attention to the number of analysts covering a stock over the course of a year. In general, the more analysts who cover the stock give the consensus rating more credibility, but each individual rating less overall weight.
Analyst ratings are one data point for you to consider. Here are some strategies you can use to fine tune your research.
Look at more than one analyst and don’t hesitate to look at analysts that have differing views. This can help challenge any preconceived ideas you have about a stock and point out ways in which your thesis for owning or avoiding a stock may have changed.
Compare a stock’s rating with other stocks in its industry or sector. In some cases, a stock is simply superior to others in its sector. However, at other times, it could be overvalued based on investor sentiment instead of fundamentals.
How are the Fintel Analyst Ratings different?Analyst ratings by Fintel are presented in close to real-time to stay ahead of generalized information flow. Combined with target price estimates and revenue estimates for the company you have greater accuracy despite market volatility.
Date | Analyst | Prior | Latest Recommendation |
Action |
---|---|---|---|---|
2024-08-05 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
2024-08-05 | Guggenheim | Buy | Buy | Maintains |
2024-08-14 | Berenberg | Buy | Buy | Maintains |
2024-10-31 | Barclays | Overweight | Overweight | Maintains |
2024-10-31 | B of A Securities | Buy | Buy | Maintains |
2025-08-11 | Deutsche Bank | Buy | Buy | Maintains |
2024-09-09 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
2024-08-16 | Guggenheim | Buy | Buy | Maintains |
2024-09-16 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
2024-08-27 | Morgan Stanley | Overweight | Overweight | Reiterate |
2024-08-19 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
2024-11-15 | Wolfe Research | Outperform | Initiate | |
2024-08-09 | Wells Fargo | Overweight | Overweight | Maintains |
2024-08-09 | BMO Capital | Outperform | Outperform | Maintains |
2024-08-09 | B of A Securities | Buy | Buy | Maintains |
2024-07-24 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
2024-07-15 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
2024-07-11 | JP Morgan | Overweight | Overweight | Maintains |
2024-07-11 | Berenberg | Buy | Buy | Maintains |
2024-07-10 | Barclays | Overweight | Overweight | Maintains |
2024-07-05 | Morgan Stanley | Overweight | Overweight | Maintains |
2024-07-03 | BMO Capital | Outperform | Outperform | Maintains |
2024-07-01 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
2024-06-26 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
2024-06-25 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
2024-06-25 | Truist Securities | Buy | Buy | Reiterate |
2024-06-24 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
2025-01-28 | Wells Fargo | Overweight | Overweight | Maintains |
2025-01-28 | Citigroup | Buy | Buy | Maintains |
2024-06-24 | B of A Securities | Buy | Buy | Maintains |
2024-06-24 | Jefferies | Buy | Buy | Maintains |
2024-06-20 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
2024-06-17 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
2024-06-12 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
2024-06-11 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
2024-06-07 | Jefferies | Buy | Buy | Maintains |
2024-05-14 | Argus Research | Buy | Buy | Maintains |
2024-05-01 | JP Morgan | Overweight | Overweight | Maintains |
2024-05-01 | BMO Capital | Outperform | Outperform | Maintains |
2024-05-01 | Cantor Fitzgerald | Overweight | Overweight | Maintains |
2024-05-01 | Truist Securities | Buy | Buy | Maintains |
2024-04-30 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
2024-04-18 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
2024-04-15 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
2024-04-11 | Goldman Sachs | Neutral | Neutral | Maintains |
2024-04-05 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
2024-04-03 | Erste Group | Hold | Buy | Upgrade |
2024-04-02 | Citigroup | Buy | Buy | Maintains |
2024-04-01 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
2024-03-22 | Truist Securities | Buy | Buy | Reiterate |
2024-03-15 | JP Morgan | Overweight | Overweight | Maintains |
2024-03-01 | B of A Securities | Buy | Buy | Maintains |
2024-02-21 | DZ Bank | Buy | Hold | Downgrade |
2024-02-20 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
2024-02-16 | Morgan Stanley | Overweight | Overweight | Maintains |
2024-02-14 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
2024-02-07 | Truist Securities | Buy | Buy | Maintains |
2024-02-07 | Morgan Stanley | Overweight | Overweight | Maintains |
2024-02-07 | Wells Fargo | Overweight | Overweight | Maintains |
2024-02-07 | Barclays | Overweight | Overweight | Maintains |
2024-02-07 | BMO Capital | Outperform | Outperform | Maintains |
2024-02-06 | Wells Fargo | Overweight | Overweight | Maintains |
2024-02-06 | Cantor Fitzgerald | Overweight | Overweight | Maintains |
2024-02-05 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
2024-02-01 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
2024-01-24 | Wells Fargo | Overweight | Overweight | Maintains |
2024-01-23 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
2024-01-23 | Barclays | Overweight | Overweight | Maintains |
2023-12-21 | Daiwa Capital | Buy | Outperform | Downgrade |
2023-11-29 | Truist Securities | Buy | Buy | Reiterate |
2023-11-20 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
2023-11-17 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
2023-11-15 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
2023-11-09 | Deutsche Bank | Hold | Initiate | |
2023-11-08 | JP Morgan | Overweight | Reiterate | |
2023-11-03 | Morgan Stanley | Overweight | Overweight | Maintains |
2023-10-23 | Citigroup | Buy | Buy | Maintains |
2023-10-23 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
2023-10-11 | Morgan Stanley | Overweight | Overweight | Maintains |
2023-10-09 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
2023-10-09 | Wells Fargo | Overweight | Overweight | Maintains |
2023-10-02 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
2023-09-05 | Morgan Stanley | Overweight | Overweight | Maintains |
2023-09-05 | Argus Research | Buy | Buy | Maintains |
2023-09-05 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
2023-08-22 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
2023-08-10 | Goldman Sachs | Neutral | Neutral | Maintains |
2023-08-09 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
2023-08-09 | Goldman Sachs | Neutral | Neutral | Maintains |
2023-08-09 | Barclays | Overweight | Overweight | Maintains |
2023-08-09 | JP Morgan | Overweight | Overweight | Maintains |
2023-08-09 | BMO Capital | Outperform | Outperform | Maintains |
2023-08-09 | Truist Securities | Buy | Buy | Maintains |
2023-08-09 | Morgan Stanley | Overweight | Overweight | Maintains |
2023-08-09 | Credit Suisse | Outperform | Outperform | Maintains |
2023-08-09 | RBC Capital | Outperform | Outperform | Maintains |
2023-08-09 | Jefferies | Hold | Buy | Upgrade |
2023-08-08 | Wells Fargo | Overweight | Overweight | Maintains |
2023-07-28 | JP Morgan | Overweight | Overweight | Maintains |
2023-07-26 | Citigroup | Buy | Buy | Maintains |
2023-07-21 | Jefferies | Hold | Hold | Maintains |
2023-07-21 | Morgan Stanley | Overweight | Overweight | Maintains |
2023-07-20 | Truist Securities | Buy | Buy | Maintains |
2023-07-17 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
2023-07-14 | HSBC | Buy | Initiate | |
2023-07-13 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
2023-07-11 | Morgan Stanley | Overweight | Overweight | Maintains |
2023-06-27 | Cantor Fitzgerald | Overweight | Overweight | Maintains |
2023-06-27 | Truist Securities | Buy | Buy | Reiterate |
2023-06-20 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
2023-05-26 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
2023-05-26 | Wells Fargo | Overweight | Overweight | Maintains |
2023-05-24 | B of A Securities | Buy | Buy | Maintains |
2023-05-23 | TD Cowen | Outperform | Maintains | |
2023-05-22 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
2023-05-15 | Morgan Stanley | Overweight | Overweight | Maintains |
2023-05-04 | BMO Capital | Outperform | Maintains | |
2023-05-04 | JP Morgan | Overweight | Maintains | |
2023-05-04 | Credit Suisse | Outperform | Maintains | |
2023-05-01 | SVB Securities | Outperform | Maintains | |
2023-05-01 | Barclays | Overweight | Maintains | |
2023-04-28 | Cantor Fitzgerald | Overweight | Maintains | |
2023-04-28 | JP Morgan | Overweight | Maintains | |
2023-04-28 | Morgan Stanley | Overweight | Maintains | |
2023-04-28 | Credit Suisse | Outperform | Maintains | |
2023-04-28 | Wells Fargo | Overweight | Maintains | |
2023-04-14 | Morgan Stanley | Overweight | Maintains | |
2023-04-11 | Guggenheim | Buy | Maintains | |
2023-04-10 | Morgan Stanley | Overweight | Maintains | |
2023-04-03 | Jefferies | Hold | Maintains | |
2023-03-13 | Wells Fargo | Equal-Weight | Overweight | Upgrade |
2023-03-06 | Jefferies | Hold | Initiate | |
2023-03-03 | Citigroup | Buy | Maintains | |
2023-03-01 | Morgan Stanley | Overweight | Maintains | |
2023-02-16 | Societe Generale | Hold | Sell | Downgrade |
2023-02-03 | Wells Fargo | Equal-Weight | Maintains | |
2023-02-03 | Morgan Stanley | Overweight | Maintains | |
2023-01-03 | Barclays | Overweight | Maintains | |
2022-12-16 | SVB Leerink | Outperform | Maintains | |
2022-12-15 | UBS | Buy | Maintains | |
2022-12-14 | Morgan Stanley | Overweight | Maintains | |
2022-12-08 | Wells Fargo | Equal-Weight | Maintains | |
2022-12-07 | Guggenheim | Buy | Maintains | |
2022-12-06 | Credit Suisse | Outperform | Maintains | |
2022-12-06 | Morgan Stanley | Overweight | Maintains | |
2022-12-05 | Cowen & Co. | Outperform | Maintains | |
2022-11-22 | Berenberg | Buy | Maintains | |
2022-11-18 | Credit Suisse | Outperform | Initiate | |
2022-11-17 | Morgan Stanley | Overweight | Maintains | |
2022-11-08 | Goldman Sachs | Neutral | Maintains | |
2022-11-02 | Barclays | Overweight | Maintains | |
2022-11-02 | Wells Fargo | Equal-Weight | Maintains | |
2022-11-02 | Morgan Stanley | Overweight | Maintains | |
2022-11-02 | SVB Leerink | Outperform | Maintains | |
2022-10-12 | Morgan Stanley | Overweight | Maintains | |
2022-09-22 | UBS | Neutral | Buy | Upgrade |
2022-09-07 | Morgan Stanley | Overweight | Maintains | |
2022-09-06 | BMO Capital | Outperform | Maintains | |
2022-07-08 | Morgan Stanley | Overweight | Maintains | |
2022-07-07 | Barclays | Overweight | Maintains | |
2022-06-01 | JP Morgan | Overweight | Maintains | |
2022-05-23 | SVB Leerink | Outperform | Initiate | |
2022-05-02 | Mizuho | Buy | Maintains | |
2022-04-29 | Morgan Stanley | Overweight | Maintains | |
2022-04-29 | BMO Capital | Outperform | Maintains | |
2022-04-29 | Wells Fargo | Equal-Weight | Maintains | |
2022-04-12 | Goldman Sachs | Neutral | Maintains | |
2022-04-06 | Morgan Stanley | Overweight | Maintains | |
2022-02-04 | Morgan Stanley | Overweight | Maintains | |
2022-02-04 | Mizuho | Buy | Maintains | |
2022-01-24 | Morgan Stanley | Overweight | Maintains | |
2022-01-21 | DZ Bank | Hold | Buy | Upgrade |
2022-01-04 | Wells Fargo | Equal-Weight | Maintains | |
2021-12-20 | Berenberg | Buy | Maintains | |
2021-12-20 | Barclays | Overweight | Maintains | |
2021-12-17 | Goldman Sachs | Neutral | Initiate | |
2021-12-09 | Wells Fargo | Equal-Weight | Initiate | |
2021-11-19 | BMO Capital | Outperform | Initiate | |
2021-10-11 | Berenberg | Hold | Buy | Upgrade |
2021-09-29 | Citigroup | Neutral | Buy | Upgrade |
2021-08-30 | Cowen & Co. | Outperform | Maintains | |
2021-08-05 | Morgan Stanley | Overweight | Maintains | |
2021-08-05 | DZ Bank | Hold | Buy | Upgrade |
2021-08-04 | Mizuho | Buy | Maintains | |
2021-08-04 | Morgan Stanley | Overweight | Maintains | |
2021-07-06 | Barclays | Overweight | Maintains | |
2021-07-02 | Truist Securities | Buy | Maintains | |
2021-06-24 | Cowen & Co. | Outperform | Maintains | |
2021-06-24 | Cantor Fitzgerald | Overweight | Maintains | |
2021-06-15 | JP Morgan | Overweight | Maintains | |
2021-06-14 | Goldman Sachs | Buy | Maintains | |
2021-04-28 | Mizuho | Buy | Maintains | |
2021-04-28 | Morgan Stanley | Overweight | Maintains | |
2021-04-28 | Barclays | Overweight | Maintains | |
2021-03-15 | Truist Securities | Buy | Maintains | |
2021-02-12 | Cowen & Co. | Outperform | Maintains | |
2021-02-04 | Morgan Stanley | Overweight | Maintains | |
2021-02-01 | Mizuho | Buy | Maintains | |
2021-02-01 | Truist Securities | Buy | Maintains | |
2021-01-22 | B of A Securities | Buy | Maintains | |
2021-01-19 | Mizuho | Neutral | Buy | Upgrade |
2020-12-10 | Wolfe Research | Peer Perform | Outperform | Upgrade |
2020-11-17 | Mizuho | Neutral | Maintains | |
2020-11-10 | Bernstein | Market Perform | Initiate | |
2020-10-28 | Morgan Stanley | Overweight | Maintains | |
2020-10-23 | Truist Securities | Buy | Initiate | |
2020-10-16 | JP Morgan | Overweight | Maintains | |
2020-09-29 | Berenberg | Hold | Initiate | |
2020-09-03 | Morgan Stanley | Equal-Weight | Overweight | Upgrade |
2020-08-14 | Morgan Stanley | Equal-Weight | Maintains | |
2020-06-17 | JP Morgan | Overweight | Maintains | |
2020-04-24 | CFRA | Hold | Maintains | |
2020-04-21 | UBS | Buy | Neutral | Downgrade |
2020-04-15 | Cowen & Co. | Outperform | Maintains | |
2020-04-09 | Morgan Stanley | Overweight | Equal-Weight | Downgrade |
2020-04-02 | Morgan Stanley | Overweight | Maintains | |
2020-03-11 | Goldman Sachs | Buy | Maintains | |
2020-02-06 | Mizuho | Neutral | Initiate | |
2019-12-30 | Argus Research | Buy | Maintains | |
2019-12-18 | JP Morgan | Overweight | Maintains | |
2019-12-18 | Morgan Stanley | Equal-Weight | Overweight | Upgrade |
2019-10-17 | UBS | Buy | Maintains | |
2019-09-10 | Bank of America | Neutral | Reiterate | |
2019-05-28 | Goldman Sachs | Buy | Initiate | |
2019-05-01 | BMO Capital | Outperform | Outperform | Maintains |
2019-04-24 | Edward Jones | Hold | Buy | Upgrade |
2019-04-11 | Guggenheim | Buy | Neutral | Downgrade |
2019-01-23 | UBS | Buy | Initiate | |
2018-11-26 | Citigroup | Buy | Neutral | Downgrade |
2018-10-31 | Credit Suisse | Underperform | Neutral | Upgrade |
2018-10-24 | Wolfe Research | Peer Perform | Initiate | |
2018-10-12 | Barclays | Overweight | Overweight | Maintains |
2018-10-05 | BMO Capital | Market Perform | Outperform | Upgrade |
2018-10-03 | BMO Capital | Market Perform | Market Perform | Maintains |
2018-09-18 | Barclays | Overweight | Overweight | Maintains |
2018-09-07 | Barclays | Overweight | Overweight | Maintains |
2018-07-31 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
2018-07-25 | Credit Suisse | Underperform | Underperform | Maintains |
2018-07-25 | Berenberg | Buy | Hold | Downgrade |
2018-07-25 | Cantor Fitzgerald | Overweight | Overweight | Maintains |
2018-07-25 | Bank of America | Neutral | Neutral | Maintains |
2018-07-25 | BMO Capital | Market Perform | Market Perform | Maintains |
2018-07-19 | BMO Capital | Market Perform | Market Perform | Maintains |
2018-07-17 | Bank of America | Neutral | Neutral | Maintains |
2018-06-22 | DZ Bank | Buy | Hold | Downgrade |
2018-06-21 | Credit Suisse | Underperform | Underperform | Maintains |
2018-06-08 | Cantor Fitzgerald | Overweight | Initiate | |
2018-04-25 | BMO Capital | Market Perform | Market Perform | Maintains |
2018-04-13 | BMO Capital | Underperform | Market Perform | Upgrade |
2018-02-01 | BMO Capital | Underperform | Underperform | Maintains |
2018-02-01 | Bank of America | Neutral | Neutral | Maintains |
2018-01-22 | Credit Suisse | Neutral | Underperform | Downgrade |
2018-01-16 | Goldman Sachs | Buy | Neutral | Downgrade |
2018-01-05 | Argus | Hold | Buy | Upgrade |
2017-11-21 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
2017-10-23 | Leerink Swann | Market Perform | Maintains | |
2017-10-13 | Barclays | Overweight | Maintains | |
2017-10-10 | BMO Capital | Underperform | Maintains | |
2017-10-10 | Credit Suisse | Outperform | Neutral | Downgrade |
2017-09-15 | Jefferies | Buy | Maintains | |
2017-09-06 | BMO Capital | Underperform | Maintains | |
2017-07-26 | Leerink Swann | Outperform | Market Perform | Downgrade |
2017-07-17 | Deutsche Bank | Buy | Maintains | |
2017-07-17 | Jefferies | Buy | Maintains | |
2017-04-27 | Argus | Buy | Hold | Downgrade |
2017-04-17 | Morgan Stanley | Overweight | Equal-Weight | Downgrade |
2017-04-17 | BMO Capital | Market Perform | Underperform | Downgrade |
2016-12-16 | Morgan Stanley | Equal-Weight | Overweight | Upgrade |
2016-11-25 | Atlantic Equities | Overweight | Neutral | Downgrade |
2016-11-25 | BMO Capital | Outperform | Market Perform | Downgrade |
2016-09-27 | Goldman Sachs | Neutral | Buy | Upgrade |
2016-09-08 | JP Morgan | Overweight | Maintains | |
2016-08-02 | Argus | Buy | Maintains | |
2016-08-02 | Argus Research | Buy | Maintains | |
2016-07-14 | Jefferies | Buy | Maintains | |
2016-05-02 | Leerink Swann | Outperform | Maintains | |
2016-05-01 | Credit Suisse | Outperform | Maintains | |
2016-04-06 | Societe Generale | Hold | Initiate | |
2016-03-15 | Jefferies | Buy | Maintains | |
2015-12-28 | Leerink Swann | Outperform | Maintains | |
2015-12-18 | Atlantic Equities | Overweight | Initiate | |
2015-12-07 | Deutsche Bank | Hold | Buy | Upgrade |
2015-12-01 | Barclays | Equal-Weight | Overweight | Upgrade |
2015-11-16 | BMO Capital | Market Perform | Outperform | Upgrade |
2015-10-13 | Leerink Swann | Outperform | Maintains | |
2015-10-09 | Credit Suisse | Neutral | Outperform | Upgrade |
2015-09-21 | JP Morgan | Neutral | Maintains | |
2015-09-18 | Jefferies | Buy | Maintains | |
2015-08-27 | Berenberg | Buy | Initiate | |
2015-08-07 | Jefferies | Buy | Maintains | |
2015-07-27 | SunTrust Robinson Humphrey | Buy | Maintains | |
2015-07-27 | Leerink Swann | Outperform | Maintains | |
2015-07-22 | Barclays | Equal-Weight | Maintains | |
2015-07-15 | Morgan Stanley | Overweight | Equal-Weight | Downgrade |
2015-07-13 | Jefferies | Buy | Maintains | |
2015-06-26 | Leerink Swann | Outperform | Maintains | |
2015-06-25 | Bank of America | Neutral | Buy | Upgrade |
2015-06-18 | Argus | Buy | Maintains | |
2015-06-18 | Argus Research | Buy | Maintains | |
2015-06-17 | PiperJaffray | Overweight | Initiate | |
2015-04-29 | Citigroup | Neutral | Buy | Upgrade |
2015-04-24 | BMO Capital | Market Perform | Maintains | |
2015-03-25 | SunTrust Robinson Humphrey | Buy | Maintains | |
2015-03-13 | Leerink Swann | Outperform | Maintains | |
2015-02-20 | Jefferies | Buy | Maintains | |
2015-02-02 | JP Morgan | Neutral | Maintains | |
2015-01-16 | Barclays | Equal-Weight | Maintains | |
2015-01-15 | Goldman Sachs | Sell | Neutral | Upgrade |
2015-01-09 | Bank of America | Buy | Neutral | Downgrade |
2015-01-08 | Jefferies | Hold | Buy | Upgrade |
2015-01-08 | Deutsche Bank | Buy | Hold | Downgrade |
2014-12-11 | Morgan Stanley | Underweight | Overweight | Upgrade |
2014-12-04 | Jefferies | Hold | Maintains | |
2014-10-27 | Argus | Buy | Maintains | |
2014-10-27 | Argus Research | Buy | Maintains | |
2014-10-13 | Jefferies | Hold | Maintains | |
2014-10-02 | Guggenheim | Buy | Initiate | |
2014-08-27 | Deutsche Bank | Buy | Initiate | |
2014-08-11 | Jefferies | Hold | Maintains | |
2014-08-01 | Tigress Financial | Buy | Initiate | |
2014-07-31 | Citigroup | Buy | Neutral | Downgrade |
2014-07-29 | Argus | Buy | Maintains | |
2014-07-29 | Argus Research | Buy | Maintains | |
2014-07-14 | Jefferies | Hold | Maintains | |
2014-07-02 | Barclays | Underweight | Equal-weight | Upgrade |
2014-04-29 | Argus | Buy | Maintains | |
2014-04-29 | Argus Research | Buy | Maintains | |
2014-04-28 | Leerink Swann | Outperform | Maintains | |
2014-04-23 | MKM Partners | Buy | Neutral | Downgrade |
2014-04-14 | Jefferies | Hold | Maintains | |
2014-04-08 | BMO Capital | Underperform | Market Perform | Upgrade |
2014-04-03 | Cowen & Co. | Market Perform | Outperform | Upgrade |
2014-04-01 | Bank of America | Buy | Maintains | |
2014-01-10 | Barclays | Equal-weight | Underweight | Downgrade |
2014-01-08 | BMO Capital | Market Perform | Underperform | Downgrade |
2013-11-11 | Goldman Sachs | Neutral | Sell | Downgrade |
2013-10-24 | MKM Partners | Neutral | Buy | Upgrade |
2013-10-11 | Jefferies | Hold | Underperform | Downgrade |
2013-10-10 | Edward Jones | Hold | Sell | Upgrade |
2013-10-08 | Credit Suisse | Neutral | Initiate | |
2013-07-25 | Barclays | Equal-Weight | Maintains | |
2013-05-29 | SunTrust Robinson Humphrey | Buy | Initiate | |
2013-05-28 | Jefferies | Underperform | Hold | Upgrade |
2013-04-10 | Jefferies | Underperform | Maintains | |
2013-01-30 | UBS | Neutral | Maintains | |
2013-01-30 | Goldman Sachs | Neutral | Maintains | |
2013-01-30 | Citigroup | Buy | Maintains | |
2013-01-30 | Barclays | Equal-Weight | Maintains | |
2013-01-17 | CLSA | Sell | Initiate | |
2013-01-16 | Jefferies | Underperform | Maintains | |
2013-01-09 | Bank of America | Buy | Maintains | |
2013-01-07 | Barclays | Equal-Weight | Maintains | |
2013-01-07 | UBS | Neutral | Maintains | |
2012-11-30 | Citigroup | Buy | Initiate | |
2012-11-29 | Citigroup | Buy | Maintains | |
2012-10-26 | BMO Capital | Market Perform | Maintains | |
2012-10-15 | Leerink Swann | Market Perform | Outperform | Upgrade |
2012-10-12 | Cowen & Co. | Neutral | Underperform | Downgrade |
2012-10-12 | Jefferies | Underperform | Maintains | |
2012-10-11 | Bank of America | Buy | Maintains | |
2012-10-09 | UBS | Neutral | Maintains | |
2012-10-09 | Goldman Sachs | Sell | Neutral | Upgrade |
2012-09-21 | UBS | Neutral | Maintains | |
2012-09-14 | Goldman Sachs | Sell | Maintains | |
2012-09-05 | Bernstein | Market Perform | Outperform | Upgrade |
2012-08-29 | Bank of America | Buy | Maintains | |
2012-08-28 | Atlantic Equities | Underweight | Overweight | Upgrade |
2012-08-24 | Credit Suisse | Neutral | Outperform | Upgrade |
2012-07-30 | Jefferies | Hold | Underperform | Downgrade |
2012-07-27 | Morgan Stanley | Underweight | Maintains | |
2012-07-18 | Morgan Stanley | Underweight | Maintains | |
2012-07-13 | Jefferies | Hold | Maintains | |
2012-06-27 | Goldman Sachs | Sell | Maintains | |
2012-05-18 | BMO Capital | Market Perform | Initiate | |
2012-05-07 | Bank oferica | Buy | Maintains | |
2024-10-25 | Citigroup | Buy | Buy | Maintains |
2024-10-03 | Deutsche Bank | Buy | Buy | Reiterate |
2024-10-17 | Bernstein | Outperform | Initiate | |
2025-03-05 | Wells Fargo | Overweight | Overweight | Maintains |
2024-09-13 | JP Morgan | Overweight | Overweight | Maintains |
2024-09-13 | Citigroup | Buy | Buy | Reiterate |
2024-11-04 | Deutsche Bank | Buy | Buy | Maintains |
2025-07-11 | Guggenheim | Buy | Buy | Maintains |
2025-02-03 | Truist Securities | Buy | Buy | Maintains |
2024-08-12 | Deutsche Bank | Hold | Buy | Upgrade |
2024-12-10 | B of A Securities | Buy | Reiterate | |
2024-10-10 | Truist Securities | Buy | Buy | Maintains |
2025-05-02 | UBS | Buy | Buy | Maintains |
2025-04-08 | Goldman Sachs | Neutral | Buy | Upgrade |
2025-06-20 | Guggenheim | Buy | Buy | Reiterate |
2025-04-09 | Morgan Stanley | Overweight | Overweight | Maintains |
2025-08-27 | HSBC | Reduce | Hold | Upgrade |
2025-04-14 | Guggenheim | Buy | Buy | Maintains |
2025-07-10 | Morgan Stanley | Overweight | Overweight | Maintains |
2025-08-08 | UBS | Buy | Buy | Maintains |
2025-04-22 | Cantor Fitzgerald | Overweight | Initiate | |
2025-04-28 | HSBC | Buy | Reduce | Downgrade |
2025-08-13 | Cantor Fitzgerald | Overweight | Overweight | Maintains |
2025-08-13 | Guggenheim | Buy | Buy | Maintains |
Revenue Estimates
No data available.
Earnings Estimates
The forecasted annual earnings of Eli Lilly and Company in 2032-12-31 is 69.25 per share.
One part of an analyst’s rating is a profit (i.e., earnings) estimate for the current quarter and/or future quarters. The measurement given is earnings per share (EPS). EPS is a metric that indicates how much a company earned as represented by one share of its stock over a specific period (typically three months).
To understand the earnings per share calculation, you must understand net income. Net income is the amount of money a company has left over after deducting appropriate expenses and taxes from its revenues).
The formula for earnings per share is net income divided by the total number of outstanding shares (i.e., available for purchase). For example:
Company A has a net income of $100 million and forty million outstanding shares. The EPS calculation is as follows:
100,000,000/40,000,000 = $2.50 per share
Earnings per share is an essential metric for you to consider when deciding to buy a stock. After all, a company with high earnings per share is productive and generates revenue in excess of its operating costs.
However, it’s not the only metric you should use. Metrics like price-to-earnings and debt-to-equity add additional perspective about a company’s health.
You should also be sure to compare a company’s EPS with a company in its sector. However, when you do, be aware that EPS is different and more important than net profit by itself. You may see a company that has a rising net profit. But if its outstanding shares are also rising, then its EPS might be flat or even edging lower.
Update Frequency: Quarterly
Date | EPS Average (Quarterly) | Number of Analysts (Quarterly) | EPS Average (Annual) | Number of Analysts (Annually) |
---|---|---|---|---|
2025-09-30 | 4.82 | 3 | -- | -- |
2025-12-31 | 5.44 | 3 | 19.54 | 28 |
2026-03-31 | 6.51 | 2 | -- | -- |
2026-06-30 | 7.26 | 2 | -- | -- |
2026-09-30 | 7.91 | 2 | -- | -- |
2026-12-31 | 7.99 | 2 | 25.67 | 22 |
2027-12-31 | -- | -- | 30.65 | 14 |
2028-12-31 | -- | -- | 36.19 | 14 |
2029-12-31 | -- | -- | 40.75 | 12 |
2030-12-31 | -- | -- | 46.30 | 12 |
2031-12-31 | -- | -- | 52.12 | 10 |
2032-12-31 | -- | -- | 69.25 | 7 |